What this means
This is a trial that is still signing up people, so no results exist yet. It will tell us later whether the walking program helps walking ability compared with usual care.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–80
- Where
- 3 sites
The science
- Registered title
- Exercise Activity to Improve Mobility in Patients With CKD and PAD
- Trial ID
- NCT06621264 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Chronic Kidney Disease Stage 3 and 4, Peripheral Artery Disease (PAD)
- What is tested
- EXERCISE TRAINING WITH OR WITHOUT MEDICATION, Control (Standard treatment)
- Sponsor
- University Hospital of Ferrara
- Ages
- 18 Years to 80 Years
- Dates
- First posted Oct 1, 2024 · updated May 31, 2025
Registry summary
People affected by chronic kidney disease and concomitant diagnosed peripheral artery disease at intermediate stages, without contraindications to exercise therapy will be invited to participate in the study.
Whose providing informed consent, will be randomly assigned to one of two groups:
- Exercise program receiving two daily 10-minute interval walking sessions at a slow increasing speed.
- Control group: receiving usual care including optimal medical therapy and nutritional advice.
Patients of both groups will be measured at baseline, after the end of the exercise program (6-month) and at follow up (12-month). Outcome measures will include walking ability by the 6-minute walking test (primary outcome) and lower limbs perfusion, body composition, quality of life, laboratory outcomes and long-term hospitalizations.
Sites (3)
- University Hospital of Ferrara, Ferrara, Italy, Italy
- Ospedale Pederzoli Peschiera del Garda, Peschiera del Garda, Italy, Italy
- Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli, Reggio Calabria, Italy, Italy